Treatment of retinitis pigmentosa-related cystoid macular edema with intravitreous ranibizumab.

Purpose:To report the results of the use of intravitreous ranibizumab for treatment of cystoid macular edema (CME) associated with retinitis pigmentosa (RP).Methods:Intravitreous ranibizumab was used to treat a patient with CME associated with RP who was unable to tolerate oral acetazolamide and did